ALCHI
News
News
ALCHIMIA SRL has become part of the MORIA Group
September 07, 2022
The Italian company ALCHIMIA SRL, one of the leading European manufacturers of medical devices […]
KERASAVE has obtained de novo grant from FDA
Find out more about KERASAVE
We are proud to announce that KERASAVE, the completely synthetic with antifungal […]
PFCLs in vitreoretinal surgery: are we looking deep enough?
In the last few years, there have been hundreds of cases of blindness due to the use of some […]
Stop the Made in Veneto swabs “But we have to be autonomous”
Interview with Jana D’Amato Tothova, R&D coordinator of Alchimia srl
Il Gazzettino di Treviso – 4th June 2020 – Primo […]
So we will transport the used swabs in maximum safety – [L’Arena di Verona]
Interview with Paolo Signori, President of Alchimia srl
L’Arena – 22th April 2020 – Primo Piano 19
From a garage to […]
First swabs “Made in Veneto” against the coronavirus COVID-19 pandemic – [Corriere di Verona]
“Swabs are essential tools to anchor the good health trend but also to provide a definitive answer to […]
ALCHI
indepth
indepth
Advances in cataract surgery: protecting the cornea with a coating gel
Over the last years, the continuous advancements to minimize surgical trauma allowed to improve outcomes and achieve faster recovery for the patient.
Several studies reported that even after the most successful cataract surgeries patients can develop ocular dry-eye […]
R&D Department
We are continuously looking for solutions able to bring real innovation in the ophthalmic field through screening and selection of raw materials, compositions and formulations, prototyping, validation of models and methods all the way through the clinical assessment of a medical device.
Latest Publication
The subject of the study entitled “A new storage medium containing amphotericin B versus Optisol-GS for preservation of human donor corneas” is the comparison between the quality of human donor corneas stored in a medium for hypothermic storage containing 2.5 μg/ml of Amphotericin B, KERASAVE (AL.CHI.MI.A SRL, Italy) and Optisol-GS (Bausch & Lomb, USA) for 14 days. Find out the results of the study.
LAST PRESENTATION
Long-term exposure to oxidative stress, such as ultraviolet radiation, can lead to ocular disease. But how does the oxidative stress impact crystalline proteins? This is the object of the R&D department presentation entitled: “Extraction of crystalline proteins from porcine eye lens and evaluation of their relation with oxidative stress”.